Prelude Therapeutics Inc (PRLD)
$3.09
Prelude Therapeutics Inc (PRLD) Share Price Forecast
Currently 11 wall-street analysts regularly analyze the financials of Prelude Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 11 analysts offering 12-month price forecasts for Prelude Therapeutics Inc (PRLD) have a share price target of $9.4. This median of share price forecast represents a 204.21% upside from the latest price of $3.09 as on 01.10.23.
Prelude Therapeutics Inc (PRLD) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Prelude Therapeutics Inc (PRLD) share price will touch around $9.4 in next 12-months.
Prelude Therapeutics Inc (PRLD) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Prelude Therapeutics Inc's share price and its median forecast price. As on 01.10.23, the difference is -61.06%
Prelude Therapeutics Inc (PRLD): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Prelude Therapeutics Inc (PRLD) Share Price : Analyst Recommendation
Based on 11 analysts tracking and researching Prelude Therapeutics Inc (PRLD) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 4 | 4 | 4 |
| Outperform | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 |
Prelude Therapeutics Inc (PRLD) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Prelude Therapeutics Inc (PRLD) is $9.4, offered by 11 analysts offering 12-month price forecasts.
Prelude Therapeutics Inc (PRLD) has a maximum of 2.04 upside potential, based on 11 analysts offering 12-month price forecasts.
Based on 11 analysts tracking and researching Prelude Therapeutics Inc (PRLD), 63.64% have a buy recommendation. Remaining 36.36% have either sell or hold recommendations.
The latest share price of Prelude Therapeutics Inc (PRLD) is $3.09 as of 01/10/2023.
7 of total 11 analysts offering stock ratings for Prelude Therapeutics Inc PRLD have recommended buy rating.
₹0 US Stocks a/c Opening Fee